Early Access — free while we kick the tires
EdgarHawk

Posard Matthew L.

Director

Director
1 filing analyzed · 1 company · Latest 2024-08-14

Companies

Company Buys Sells Direction
HALOZYME THERAPEUTICS, INC. HALO 0 3 Net selling

Activity

August 2024
medium
Sell
29,881 shares
$1,689,294
Significance 5/10

Director Posard sold 29,881 shares of HALO for $1.7M across Aug 12-14 at blended avg $56.53, reducing stake 30% to 69.9K shares.

Director Matthew L. Posard executed 3 separate sales totaling 29,881 shares for $1,689,293.70 over three consecutive trading days (August 12–14, 2024), at prices ranging from $55.72 to $57.70 and a blended average of $56.53. The sales reduced his direct holdings by 30%, from 99,755 shares to 69,874 shares. At the current price of $57.41, the stock is trading at its 52-week high (+0.0% from top), with strong momentum—up 9.2% over 30 days and 26.5% over 90 days. Posard's prior two sales at HALO (June 11–12, 2024) both generated modest 30-day positive returns (+5.1% and +5.6%), and his cross-ticker track record shows 2 prior sells with an average 30-day return of +5.3%, neither of which proved well-timed at the 90-day mark. The execution of a material 30% reduction in holdings during a period of strong upward price momentum and at the stock's 52-week peak forms a notable pattern in context of the director's modest prior sale timing track record.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access